By Sabela Ojea

Philip Morris International Inc. said Wednesday that it has appointed two former U.S. Food and Drug Administration officials to work on the company's scientific transformation and smoke-free products.

The cigarette maker said it has named Badrul Chowdhury as the chief life sciences officer for its smoke-free products, and Matthew Holman as the vice president of its U.S. scientific engagement and regulatory strategy.

Mr. Chowdhury, who oversaw the FDA's center for drug evaluation and research's pulmonary division for more than 20 years, will join the company's senior management team in January 2023, it said.

Mr. Holman, who most recently worked as the FDA's director of science officer at the center for tobacco products, also spent 20 years at the federal agency, the company said.

"As we transform, we recognize the importance of bringing together diverse perspectives, including those of regulatory bodies and the scientific community," Deepak Mishra, president of PMI Americas, said.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

September 14, 2022 07:59 ET (11:59 GMT)

Philip Morris (NYSE:PM)
Historical Stock Chart
From Dec 2022 to Jan 2023

Philip Morris (NYSE:PM)
Historical Stock Chart
From Jan 2022 to Jan 2023